The length of time this chemical stays in the body or continues to show in a drug test depends on many factors, including a person’s body composition, cannabis use, and the test’s sensitivity.

Importantly, the chart doesn't illustrate how drug companies themselves benefit from rebates. Take Sanofi, which paid $7.3 billion in "discretionary" rebates last year, to commercial health ...